OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study
Tomohiro Katsuya, Yoshito Inobe, Kazuaki Uchiyama, et al.
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 835-848
Open Access | Times Cited: 12
Tomohiro Katsuya, Yoshito Inobe, Kazuaki Uchiyama, et al.
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 835-848
Open Access | Times Cited: 12
Showing 12 citing articles:
Home blood pressure-lowering effect of a non-steroidal mineralocorticoid receptor blocker, esaxerenone, versus trichlormethiazide for uncontrolled hypertension: the EXCITE-HT randomized controlled study
Kazuomi Kario, Hiroyuki Ohbayashi, Masami Hashimoto, et al.
Hypertension Research (2024) Vol. 47, Iss. 9, pp. 2435-2446
Open Access | Times Cited: 9
Kazuomi Kario, Hiroyuki Ohbayashi, Masami Hashimoto, et al.
Hypertension Research (2024) Vol. 47, Iss. 9, pp. 2435-2446
Open Access | Times Cited: 9
Factors influencing the efficacy and safety of esaxerenone in hypertensive patients: a pooled analysis of five clinical studies on different comorbidities
Kazuomi Kario, Tomohiro Katsuya, Jun Wada, et al.
Hypertension Research (2024) Vol. 47, Iss. 10, pp. 2826-2839
Open Access | Times Cited: 3
Kazuomi Kario, Tomohiro Katsuya, Jun Wada, et al.
Hypertension Research (2024) Vol. 47, Iss. 10, pp. 2826-2839
Open Access | Times Cited: 3
Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive rats
Shota Ikeda, Keisuke Shinohara, Soichiro Kashihara, et al.
Hypertension Research (2024) Vol. 47, Iss. 8, pp. 2133-2143
Closed Access | Times Cited: 2
Shota Ikeda, Keisuke Shinohara, Soichiro Kashihara, et al.
Hypertension Research (2024) Vol. 47, Iss. 8, pp. 2133-2143
Closed Access | Times Cited: 2
Home blood pressure-lowering effect of esaxerenone versus trichlormethiazide for uncontrolled hypertension: a predefined subanalysis of the EXCITE-HT randomized controlled trial by basal calcium channel blocker versus angiotensin receptor blocker
Kazuomi Kario, Hiroyuki Ohbayashi, Masami Hashimoto, et al.
Hypertension Research (2024)
Open Access | Times Cited: 2
Kazuomi Kario, Hiroyuki Ohbayashi, Masami Hashimoto, et al.
Hypertension Research (2024)
Open Access | Times Cited: 2
Molecular Imaging of Renin Activity using Fluorogenic Nanoprobes for Precision Antihypertensive Therapy
Ya Zhou, Weiping Xu, Bankang Ruan, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Ya Zhou, Weiping Xu, Bankang Ruan, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Alpha-adducin 1 (rs4961) gene and its expression associated with sodium sensitivity in hypertensive patients: a cohort study in the western Ukrainian population
Larysa Sydorchuk, Bogdan Lytvyn, Andrii Sydorchuk, et al.
Endocrine Regulations (2024) Vol. 58, Iss. 1, pp. 195-205
Open Access | Times Cited: 1
Larysa Sydorchuk, Bogdan Lytvyn, Andrii Sydorchuk, et al.
Endocrine Regulations (2024) Vol. 58, Iss. 1, pp. 195-205
Open Access | Times Cited: 1
Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
Kazuomi Kario, Tomohiro Katsuya, Tatsuo Shimosawa, et al.
Journal of Clinical Hypertension (2024)
Open Access | Times Cited: 1
Kazuomi Kario, Tomohiro Katsuya, Tatsuo Shimosawa, et al.
Journal of Clinical Hypertension (2024)
Open Access | Times Cited: 1
Effects of esaxerenone, a nonsteroidal mineralocorticoid receptor blocker, independent of urinary sodium/potassium ratio and salt intake
Satoshi Morimoto, Atsuhiro Ichihara
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 970-971
Open Access
Satoshi Morimoto, Atsuhiro Ichihara
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 970-971
Open Access
Salt and seasonal variation research in Asia
Kazuomi Kario, Satoshi Hoshide, Masaki Mogi
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 833-834
Closed Access
Kazuomi Kario, Satoshi Hoshide, Masaki Mogi
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 833-834
Closed Access
Antihypertensive effect of esaxerenone and correlation between brachial and wrist home monitoring devices in patients with nocturnal hypertension: A post hoc analysis of the EARLY‐NH study
Kazuomi Kario, Kazuhito Shiosakai, Takashi Taguchi
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 7, pp. 842-849
Open Access
Kazuomi Kario, Kazuhito Shiosakai, Takashi Taguchi
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 7, pp. 842-849
Open Access
Will esaxerenone be added to the antihypertensive treatment strategy of practicing physicians as a second-line antihypertensive drug?
Tetsuro Yoshida
Hypertension Research (2024) Vol. 47, Iss. 9, pp. 2574-2576
Closed Access
Tetsuro Yoshida
Hypertension Research (2024) Vol. 47, Iss. 9, pp. 2574-2576
Closed Access
Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism
Yuichi Yoshida, Hirotaka Shibata
Hypertension Research (2024)
Closed Access
Yuichi Yoshida, Hirotaka Shibata
Hypertension Research (2024)
Closed Access
